#EXP00017

General

Accession EXP00017
Activity Preformed biofilm
Date 2013-11-10
Administration In solution
Model in vitro
Organism Stenotrophomonas maltophilia
Status Validated
Notes Sm109 clinical isolate

Peptide

BMAP-28

GGLRSLGRKILRAWKKYGPIIVPIIRI

Experimental activity

Method Concentration Notes
Total countable CFUs 5.207 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814